Lorne Steinberg Wealth Management Inc. Mannkind Corp Transaction History

Lorne Steinberg Wealth Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$2.62 - $4.45 $76,776 - $130,402	-29,304 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.05 - $5.37 $118,681 - $157,362	29,304 New	29,304 $128,000
Q2 2021 Jul 20, 2021	SELL	$3.61 - $5.45 $105,787 - $159,706	-29,304 Closed	0 $0
Q4 2020 Mar 17, 2021	BUY	$1.79 - $4.04 $52,454 - $118,388	29,304 New	29,304 $91,000

245

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.78B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Lorne Steinberg Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Lorne Steinberg Wealth Management Inc. with notifications on news.